Cargando…

Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers

Signal Transducer and Activator of Transcription (STAT) 3 and 5 are important effectors of cellular transformation, and aberrant STAT3 and STAT5 signaling have been demonstrated in hematopoietic cancers. STAT3 and STAT5 are common targets for different tyrosine kinase oncogenes (TKOs). In addition,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brachet-Botineau, Marie, Polomski, Marion, Neubauer, Heidi A., Juen, Ludovic, Hédou, Damien, Viaud-Massuard, Marie-Claude, Prié, Gildas, Gouilleux, Fabrice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016966/ https://www.ncbi.nlm.nih.gov/pubmed/31963765 http://dx.doi.org/10.3390/cancers12010240

Ejemplares similares

A Novel Inhibitor of STAT5 Signaling Overcomes Chemotherapy Resistance in Myeloid Leukemia Cells
por: Brachet-Botineau, Marie, et al.
Publicado: (2019)

Acriflavine targets oncogenic STAT5 signaling in myeloid leukemia cells
por: Hallal, Rawan, et al.
Publicado: (2020)

VAS3947 Induces UPR-Mediated Apoptosis through Cysteine Thiol Alkylation in AML Cell Lines
por: El Dor, Maya, et al.
Publicado: (2020)

Oncogenic STAT5 signaling promotes oxidative stress in chronic myeloid leukemia cells by repressing antioxidant defenses
por: Bourgeais, Jerome, et al.
Publicado: (2016)

New Quinoxaline Derivatives as Dual Pim-1/2 Kinase Inhibitors: Design, Synthesis and Biological Evaluation
por: Oyallon, Bruno, et al.
Publicado: (2021)

Oxidative metabolism in cancer: A STAT affair?
por: Bourgeais, Jérome, et al.
Publicado: (2013)

STAT5A/5B-specific expansion and transformation of hematopoietic stem cells
por: Ghanem, S, et al.
Publicado: (2017)

Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer
por: Wingelhofer, Bettina, et al.
Publicado: (2018)

O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies
por: Freund, P, et al.
Publicado: (2017)

STAT3 and STAT5 Activation in Solid Cancers
por: Igelmann, Sebastian, et al.
Publicado: (2019)

In Vitro Characterization and Stability Profiles of Antibody–Fluorophore Conjugates Derived from Interchain Cysteine Cross-Linking or Lysine Bioconjugation
por: Martin, Camille, et al.
Publicado: (2019)

Impact of Maleimide Disubstitution on Chemical and Biological Characteristics of HER2 Antibody–Drug Conjugates
por: Feuillâtre, Ofelia, et al.
Publicado: (2020)

Opioids drive breast cancer metastasis through the δ-opioid receptor and oncogenic STAT3
por: Tripolt, Sabrina, et al.
Publicado: (2021)

Direct Targeting Options for STAT3 and STAT5 in Cancer
por: Orlova, Anna, et al.
Publicado: (2019)

PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma
por: Garces de los Fayos Alonso, I., et al.
Publicado: (2022)

Structural Implications of STAT3 and STAT5 SH2 Domain Mutations
por: de Araujo, Elvin D., et al.
Publicado: (2019)

α-Lithiation and Electrophilic Substitution of 1,4,4-Trimethyl-3,4-dihydroquinolin-2-one
por: Sébastien, Bouclé, et al.
Publicado: (2010)

Effective targeting of STAT5-mediated survival in myeloproliferative neoplasms using ABT-737 combined with rapamycin
por: Li, Geqiang, et al.
Publicado: (2010)

Role of STAT3 in In Vitro Transformation Triggered by TRK Oncogenes
por: Miranda, Claudia, et al.
Publicado: (2010)

Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumors
por: Lee, Matilda, et al.
Publicado: (2018)

PCBP1 inhibits the expression of oncogenic STAT3 isoform by targeting alternative splicing of STAT3 exon 23
por: Wang, Xiaole, et al.
Publicado: (2019)

Dibenzofuran Derivatives Inspired from Cercosporamide as Dual Inhibitors of Pim and CLK1 Kinases
por: Dao, Viet Hung, et al.
Publicado: (2021)

Pharmacologic inhibition of STAT5 in acute myeloid leukemia
por: Wingelhofer, Bettina, et al.
Publicado: (2018)

TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma
por: Lv, Deguan, et al.
Publicado: (2017)

Targeting STAT3 and STAT5 in Tumor-Associated Immune Cells to Improve Immunotherapy
por: Verdeil, Grégory, et al.
Publicado: (2019)

Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
por: Harel, Sivan, et al.
Publicado: (2015)

Pharmacological Effects of Polyphenol Phytochemicals on the JAK-STAT Signaling Pathway
por: Yin, Qianqian, et al.
Publicado: (2021)

Pharmacological inhibition of demethylzeylasteral on JAK-STAT signaling ameliorates vitiligo
por: Chang, Yuqian, et al.
Publicado: (2023)

STAT3 as a mediator of oncogenic cellular metabolism: Pathogenic and therapeutic implications
por: Tošić, Isidora, et al.
Publicado: (2021)

Oncogenic Cooperation Between IL7R-JAK-STAT Pathway Mutations
por: Lodewijckx, Inge, et al.
Publicado: (2021)

Transcriptional regulation by STAT1 and STAT2 in the interferon JAK-STAT pathway
por: Au-Yeung, Nancy, et al.
Publicado: (2013)

Targeting STAT3 and STAT5 in Cancer
por: de Araujo, Elvin D., et al.
Publicado: (2020)

STAT5-mediated self-renewal of normal hematopoietic and leukemic stem cells
por: Schepers, Hein, et al.
Publicado: (2012)

Emancipation from transcriptional latency: unphosphorylated STAT5 as guardian of hematopoietic differentiation
por: Decker, Thomas
Publicado: (2016)

Expression of JAK3, STAT2, STAT4, and STAT6 in pemphigus vulgaris
por: Juczynska, K., et al.
Publicado: (2020)

P993: INCREASED STAT5B LEVELS IN MYELOPROLIFERATIVE NEOPLASMS LEAD TO ENHANCED MEGAKARYOCYTIC DIFFERENTIATION CORRELATING WITH THROMBOSIS
por: Ploderer, Marie, et al.
Publicado: (2023)

The cnidarian origin of the proto-oncogenes NF-κB/STAT and WNT-like oncogenic pathway drives the ctenophores (Review)
por: SINKOVICS, JOSEPH G.
Publicado: (2015)

The cnidarian origin of the proto-oncogenes NF-κB/STAT and WNT-like oncogenic pathway drives the ctenophores (Review)
por: Sinkovics, Joseph G.
Publicado: (2016)

Stat1 Phosphorylation Determines Ras Oncogenicity by Regulating p27(Kip1)
por: Wang, Shuo, et al.
Publicado: (2008)

How should we define STAT3 as an oncogene and as a potential target for therapy?
por: Sellier, Hélène, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qou96vn7a9uuj2q43fijs758fg